|
Recent Developments |
|
05-MAR-18
UPL announced that its wholly owned subsidiary, UPL Corporation (formerly Biowin Corporation) has successfully completed the pricing of its USD 300 million senior unsecured notes ('Notes') at 4.5 % per annum, due 2028.
22-SEP-16
UPL, a leading global generic player in the agro chemical industry, has divested entire stake in its joint venture (JV) United Phosphorus (Bangladesh).
15-JUN-16
UPL, leading global generic player in the a... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2017(9) | 31-Mar-2017 (12) | 31-Mar-2016(12) | | Net sales | 57380.00 | 72767.20 | 58217.50 | | Other Income | 4210.00 | 3253.30 | 4572.00 | | Total Income | 61590.00 | 76020.50 | 62789.50 | | Cost of goods sold | 49940.00 | 71388.10 | 51569.20 | | OPBDIT | 11650.00 | 4632.40 | 11220.30 | | PAT | 6550.00 | 2446.00 | 7057.10 | | Gross Block | - | - | - | | Equity capital | - | 0.00 | 857.20 | | EPS (Rs.) | - | 0.00 | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 18.9 | 6.1 | 17.9 | | Net margin (% of OI) | 10.6 | 3.2 | 11.2 |
|
|
Detailed Financials
|
|
|
|
|
